Trends in HIV-1 incidence in a cohort of prostitutes in Kenya: Implications for HIV-1 vaccine efficacy trials

被引:0
|
作者
Baeten, JM
Richardson, BA
Martin, HL
Nyange, PM
Lavreys, L
Ngugi, EN
Mandaliya, K
Ndinya-Achola, JO
Bwayo, JJ
Kreiss, JK
机构
[1] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[2] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[3] Univ Washington, Dept Med, Seattle, WA 98104 USA
[4] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[5] Univ Nairobi, Dept Community Hlth, Nairobi, Kenya
[6] Coastal Prov Gen Hosp, Mombasa, Kenya
关键词
HIV-1; incidence; vaccine; prostitutes; sexual behavior; STD; Africa;
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Accurate predictions of HIV-1 incidence in potential study populations are essential for designing HIV-1 vaccine efficacy trials. Little information is available on the estimated incidence of HIV-I in such populations, especially information on incidence over time and incidence while participating in risk-reduction programs. Objectives: To examine time trends in HIV-1 incidence in a vaccine preparedness cohort. Design: Prospective cohort study of female prostitutes in Mombasa, Kenya. Methods: HIV-1 incidence was determined using open and closed cohort designs. Generalized estimating equations were used to model HIV-1 and sexually transmitted disease (STD) incidence and sexual risk behaviors over time. Results: When analyzed as a closed cohort, HIV-1 incidence declined 10-fold during 3 years of follow-up (from 17.4 to 1.7 cases/100 person-years; p <.001). More than 50% of the cases of HIV-1 occurred during the first 6 months after enrollment, and 73% during the first 12 months. When analyzed as an open cohort, HIV-1 incidence density fell during the first 4 calendar years, influenced by accumulation of lower risk participants and variations in study recruitment. Significant declines occurred in both STD incidence and high-risk sexual behaviors during follow-up. Conclusions: This study documents a dramatic decline in the risk of HIV-1 infection while participating in a prospective cohort, with most seroconversions occurring within 1 year of enrollment. Variations in HIV-1 incidence within high-risk populations should be anticipated during the design of vaccine trials.
引用
收藏
页码:458 / 464
页数:7
相关论文
共 50 条
  • [41] Diversity of Antibody Germline Gene and HIV-1 Infection: Implication for HIV-1 Vaccine
    Guan, Yongjun
    Yu, Lei
    Zhan, Ming
    Gallo, Robert C.
    Liu, Tongyun
    Sajadi, Mohammad
    DeVico, Anthony L.
    Lewis, George K.
    [J]. JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2013, 62 : 53 - 53
  • [42] HIV-1 vaccine induced immune responses in newborns of HIV-1 infected mothers
    McFarland, Elizabeth J.
    Johnson, Daniel C.
    Muresan, Petronella
    Fenton, Terence
    Tomaras, Georgia D.
    McNamara, James
    Read, Jennifer S.
    Douglas, Steven D.
    Deville, Jaime
    Gurwith, Marc
    Gurunathan, Sanjay
    Lambert, John S.
    [J]. AIDS, 2006, 20 (11) : 1481 - 1489
  • [43] HIV-1 INCIDENCE, FOLLOW-UP RATES, AND SEROTYPES IN HIGH-RISK COHORTS IN THAILAND - IMPLICATIONS FOR HIV VACCINE PHASE-III EFFICACY TRIALS
    WENIGER, BG
    MASTRO, TD
    LIMPAKARNJANARAT, K
    KITAYAPORN, D
    YOUNG, NL
    [J]. AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 : S247 - S247
  • [44] HIV-1 Infections During Vaccine Trials: Identifying New Epitopes For Differential Diagnosis Of HIV-1 Infections In The Face Of Vaccine -Induced Antibodies
    Hana Golding
    James Needham
    Surender Khurana
    [J]. Retrovirology, 2
  • [45] The prevalence and incidence of HIV-1 infection and syphilis in a cohort of police officers in Dar es Salaam, Tanzania:: a potential population for HIV vaccine trials
    Bakari, M
    Lyamuya, E
    Mugusi, F
    Aris, E
    Chale, S
    Magao, P
    Jossiah, R
    Janabi, M
    Swai, A
    Pallangyo, N
    Sandström, E
    Mhalu, F
    Biberfeld, G
    Pallangyo, K
    [J]. AIDS, 2000, 14 (03) : 313 - 320
  • [46] HIV-1 INCIDENCE AND HIV-1-ASSOCIATED MORTALITY IN A RURAL UGANDAN POPULATION COHORT
    MULDER, DW
    NUNN, AJ
    WAGNER, HU
    KAMALI, A
    KENGEYAKAYONDO, JF
    [J]. AIDS, 1994, 8 (01) : 87 - 92
  • [47] PedVACC 001 and 002: building foundations for infant HIV-1 vaccine trials against breast milk transmission of HIV-1
    Hanke, T.
    [J]. TROPICAL MEDICINE & INTERNATIONAL HEALTH, 2012, 17 : 3 - 3
  • [48] Unexplained high HIV-1 incidence in a cohort of Malawi men
    Gisselquist, D
    [J]. SEXUALLY TRANSMITTED DISEASES, 2003, 30 (02) : 183 - 184
  • [49] HIV-1 (co)Receptors: Implications for Vaccine and Therapy Design
    Pollakis, Georgios
    Paxton, William A.
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2010, 16 (33) : 3701 - 3715
  • [50] HIV-1 drug resistance and genetic diversity in a cohort of people with HIV-1 in Nigeria
    Oluniyi, Paul E.
    Ajogbasile, Fehintola, V
    Zhou, Shuntai
    Fred-Akintunwa, Iyanuoluwa
    Polyak, Christina S.
    Ake, Julie A.
    Tovanabutra, Sodsai
    Iroezindu, Michael
    Rolland, Morgane
    Happi, Christian T.
    [J]. AIDS, 2022, 36 (01) : 137 - 146